Abstract
The effect of pharmacones clathration with glycosides results in significant decrease of drug agent dosage. We investigated the clathrates of hypotensive agent Nifedipine with glycyrrhizic acid, which was prepared in molecular proportion 1:4 respectively. Present study was carried out on the calcium channels on neurons of Lymnaea stagnalis mollusc.
Keywords: Pharmacones clathration, Nifedipine, Glycyrrhizic acid, Calcium channels
Letters in Drug Design & Discovery
Title: Increase in Pharmacological Activity of Drugs in their Clathrates with Plant Glycosides
Volume: 4 Issue: 3
Author(s): T. G. Tolstikova, A. O. Bryzgalov, I. V. Sorokina, M. V. Hvostov, A. S. Ratushnyak, T. A. Zapara and O. G. Simonova
Affiliation:
Keywords: Pharmacones clathration, Nifedipine, Glycyrrhizic acid, Calcium channels
Abstract: The effect of pharmacones clathration with glycosides results in significant decrease of drug agent dosage. We investigated the clathrates of hypotensive agent Nifedipine with glycyrrhizic acid, which was prepared in molecular proportion 1:4 respectively. Present study was carried out on the calcium channels on neurons of Lymnaea stagnalis mollusc.
Export Options
About this article
Cite this article as:
Tolstikova G. T., Bryzgalov O. A., Sorokina V. I., Hvostov V. M., Ratushnyak S. A., Zapara A. T. and Simonova G. O., Increase in Pharmacological Activity of Drugs in their Clathrates with Plant Glycosides, Letters in Drug Design & Discovery 2007; 4 (3) . https://dx.doi.org/10.2174/157018007780077453
DOI https://dx.doi.org/10.2174/157018007780077453 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protective Effects of Anesthetics on the Spinal Cord
Current Pharmaceutical Design Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review
Current Organic Chemistry Angiogenesis and the Heart
Recent Patents on Cardiovascular Drug Discovery Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients
Current HIV Research Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Nitric Oxide Pathway as New Drug Targets for Refractory Hypertension
Current Pharmaceutical Design Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response
Current Neuropharmacology Levosimendan: From Basic Science to Clinical Trials
Recent Patents on Cardiovascular Drug Discovery Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation
Current Drug Delivery Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design